Activation of PI3K-mTOR signaling through PTEN (phosphatase and tensin homologue) inactivation was thought to sensitize tumors to mTOR inhibition, but no correlation of PTEN status and temsirolimus response in RCC was found in the same study [38]. Here, PTEN is linked to renal cell carcinoma.